272 related articles for article (PubMed ID: 36950480)
1. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
[TBL] [Abstract][Full Text] [Related]
2. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series.
Kolev M; Sarbu AC; Möller B; Maurer B; Kollert F; Semmo N
J Transl Autoimmun; 2023; 6():100189. PubMed ID: 36718275
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
5. The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoantibodies in Patients From a Tertiary Care Center in Pakistan.
Abbas Z; Asim M; Saeed A; Siddiqui B; Abbas M
Cureus; 2021 Nov; 13(11):e19789. PubMed ID: 34820249
[TBL] [Abstract][Full Text] [Related]
6. Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
D'Amato D; De Vincentis A; Malinverno F; Viganò M; Alvaro D; Pompili M; Picciotto A; Palitti VP; Russello M; Storato S; Pigozzi MG; Calvaruso V; De Gasperi E; Lleo A; Castellaneta A; Pellicelli A; Cazzagon N; Floreani A; Muratori L; Fagiuoli S; Niro GA; Feletti V; Cozzolongo R; Terreni N; Marzioni M; Pellicano R; Pozzoni P; Baiocchi L; Chessa L; Rosina F; Bertino G; Vinci M; Morgando A; Vanni E; Scifo G; Sacco R; D'Antò M; Bellia V; Boldizzoni R; Casella S; Omazzi B; Poggi G; Cristoferi L; Gerussi A; Ronca V; Venere R; Ponziani F; Cannavò M; Mussetto A; Fontana R; Losito F; Frazzetto E; Distefano M; Colapietro F; Labanca S; Marconi G; Grassi G; Galati G; O'Donnell SE; Mancuso C; Mulinacci G; Palermo A; Claar E; Izzi A; Picardi A; Invernizzi P; Carbone M; Vespasiani-Gentilucci U;
JHEP Rep; 2021 Apr; 3(2):100248. PubMed ID: 33681748
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
8. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.
Taneja S; Kumar P; Mitra S; Duseja A; Minz R; Das A; Dhiman RK; Chawla Y
J Clin Exp Hepatol; 2018 Mar; 8(1):98-103. PubMed ID: 29743801
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
10. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
Biewenga M; Heidt S; Vergunst M; Marijnissen CMJ; de Man RA; van der Eijk AA; van der Meer AJ; Trouw LA; van Hoek B
JHEP Rep; 2022 May; 4(5):100460. PubMed ID: 35368991
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysis.
Kolev M; Diem S; Diem L; Rodrigues SG; Berzigotti A; Stirnimann G; Semmo N
J Transl Autoimmun; 2022; 5():100172. PubMed ID: 36451933
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune liver disease - are there spectra that we do not know?
Fallatah HI; Akbar HO
Comp Hepatol; 2011 Sep; 10():9. PubMed ID: 21910861
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.
Shen ZX; Wu DD; Xia J; Wang XB; Zheng X; Huang Y; Li BL; Meng ZJ; Gao YH; Qian ZP; Liu F; Lu XB; Shang J; Yan HD; Zheng YB; Gu WY; Zhang Y; Wei JY; Tan WT; Hou YX; Zhang Q; Xiong Y; Zou CC; Chen J; Huang ZB; Jiang XH; Luo S; Chen YY; Gao N; Liu CY; Yuan W; Mei X; Li J; Li T; Zhou XY; Deng GH; Chen JJ; Ma X; Li H
World J Gastroenterol; 2022 Aug; 28(31):4417-4430. PubMed ID: 36159019
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
[TBL] [Abstract][Full Text] [Related]
16. Biliary features in liver histology of children with autoimmune liver disease.
Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
18. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.
Lee DU; Ponder R; Lee K; Menegas S; Fan GH; Chou H; Jung D; Lee K; Hastie DJ; Urrunaga NH
Hepatol Int; 2023 Jun; 17(3):720-734. PubMed ID: 36575337
[TBL] [Abstract][Full Text] [Related]
19. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L
Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269
[TBL] [Abstract][Full Text] [Related]
20. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
